These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33939759)

  • 1. The European tomato market. An approach by export competitiveness maps.
    Capobianco-Uriarte MLM; Aparicio J; De Pablo-Valenciano J; Casado-Belmonte MDP
    PLoS One; 2021; 16(5):e0250867. PubMed ID: 33939759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Export competitiveness of dairy products on global markets: the case of the European Union countries.
    Bojnec Š; Fertő I
    J Dairy Sci; 2014 Oct; 97(10):6151-63. PubMed ID: 25064651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bananas, coffee and palm oil: The trade of agricultural commodities in the framework of the EU-Colombia free trade agreement.
    Cubillos T JP; Soltész B; Vasa L
    PLoS One; 2021; 16(8):e0256242. PubMed ID: 34428244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has the European union achieved a single pharmaceutical market?
    Timur A; Picone G; DeSimone J
    Int J Health Care Finance Econ; 2011 Dec; 11(4):223-44. PubMed ID: 21984119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Openings and Competitiveness of Forward Markets: Experimental Evidence.
    Ferreira JL; Kujal P; Rassenti S
    PLoS One; 2016; 11(7):e0158098. PubMed ID: 27442516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitiveness analysis of fresh tomatoes in Indonesia: Turning comparative advantage into competitive advantage.
    Saptana ; Sukmaya SG; Perwita AD; Malihah FD; Wardhana IW; Pitaloka AD; Ghaisani SA; Sayaka B; Ilham N; Karmawati E; Ariani M; Susilowati SH; Sumaryanto ; Saliem HP
    PLoS One; 2023; 18(11):e0294980. PubMed ID: 38033136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting fluctuations in China's aquatic product exports to Japan, the USA, South Korea, Southeast Asia, and the EU.
    Miao M; Liu H; Chen J
    Aquac Int; 2021; 29(6):2507-2533. PubMed ID: 34421231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey data on organizational resources and capabilities, export marketing strategy, export competitiveness, and firm performance in exporting firms in Indonesia.
    Heriqbaldi U; Jayadi A; Erlando A; Samudro BR; Widodo W; Esquivias MA
    Data Brief; 2023 Jun; 48():109112. PubMed ID: 37101779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the market share of generic medicines influence the price level?: a European analysis.
    Dylst P; Simoens S
    Pharmacoeconomics; 2011 Oct; 29(10):875-82. PubMed ID: 21797288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors].
    Mahlich JC; Stadler I
    Gesundheitswesen; 2012 Jan; 74(1):23-8. PubMed ID: 21154203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do National Export Promotion Programs in Indonesia support export competitiveness?
    Heriqbaldi U; Esquivias MA; Samudro BR; Widodo W
    Heliyon; 2023 Jun; 9(6):e16918. PubMed ID: 37332974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreign market selection process as tool for international expansion: Case study for ecuadorian chia seeds exports to the european union.
    Terán-Yépez E; Santos-Roldán L; Palacios-Florencio B; Berbel-Pineda JM
    An Acad Bras Cienc; 2020; 92(1):e20190513. PubMed ID: 32321027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does capital structure change product-market competitiveness? Evidence from Chinese firms.
    Li L; Wang Z
    PLoS One; 2019; 14(2):e0210618. PubMed ID: 30721237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing economic freedom against social policy principles: EC competition law and national health systems.
    Mossialos E; Lear J
    Health Policy; 2012 Jul; 106(2):127-37. PubMed ID: 22502932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience.
    Bocquet F; Loubière A; Fusier I; Cordonnier AL; Paubel P
    Pharmacoeconomics; 2016 Nov; 34(11):1173-1186. PubMed ID: 27412251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the market and consumption of pulses in Europe.
    Schneider AV
    Br J Nutr; 2002 Dec; 88 Suppl 3():S243-50. PubMed ID: 12498623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stock market comovements among Asian emerging economies: A wavelet-based approach.
    Younis I; Longsheng C; Basheer MF; Joyo AS
    PLoS One; 2020; 15(10):e0240472. PubMed ID: 33044995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From heterogeneity to harmonization? Recent trends in European health policy.
    Gerlinger T; Urban HJ
    Cad Saude Publica; 2007; 23 Suppl 2():S133-42. PubMed ID: 17625641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research & market strategy: how choice of drug discovery approach can affect market position.
    Sams-Dodd F
    Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.